Orthopedic Implants Market is expected to gain market growth at a CAGR of 5.35% in the forecast period of 2022 to 2029 and is expected to reach USD 68,359.6 million by 2029. Orthopedic Implants Market report contains detailed information on factors influencing opportunities, demand, growth, challenges, drivers, and restraints. It provides detailed information about the structure of global and regional industries. The report also includes data on research & development, new product launches, product responses from the global and local markets by leading players. The structured analysis offers a graphical representation and a diagrammatic breakdown of the Orthopedic Implants Market by region.
The orthopedic implants market is anticipated to grow at a faster pace due to high risk of osteoporosis and oerstoarthitis becomes more common as one comes near old age Also the, soaring number of road accidents and sports injuries is incessantly engendering the multitude of worldwide trauma cases thus lifting the demand of the orthopedic implants market over the forecast period of 2021 to 2028.
Download Free Sample Report to explore growth opportunities in the Orthopedic Implants market@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-orthopedic-implants-market
Drivers
· Increasing cases of orthopedic surgeries
· Rise in the number of geriatric population
Recent Development
In December 2021, DePuy Synthes, a branch of Johnson & Johnson, announced the acquisition of OrthoSpin through its Synthes GmbH affiliate. OrthoSpin is an Israeli company that develops a robotic-assisted external fixation method for orthopaedic treatments.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Orthopedic implants market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for orthopedic implants market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the orthopedic implants market.
Orthopedic Implants Market Scope and Size-
· Based on product type, the orthopedic implants market is segmented into reconstructive joint replacements, spinal implants, dental implants, orthobiologics, trauma and craniomaxillofacial implants and others. Reconstructive joint replacements have further been segmented into knee replacement implants, hip replacement implants and extremities. Extremities have further sub-segmented into upper extremity reconstruction and lower extremity reconstruction.
· On the basis of biomaterial, the orthopedic implants market is segmented into ceramics biomaterials, metallic biomaterials, polymeric biomaterials and natural biomaterials constipation.
· Based on procedure, the orthopedic implants market is segmented into open surgery, minimally invasive surgery (MIS) and others.
· On the basis of device type, the orthopedic implants market is segmented into internal fixation devices and external fixation devices. External fixation devices have further been segmented into orthopedic rods/wire, orthopedic screws, orthopedic plates, fixation pins and orthopedic nails sodium phosphate enemas.
· The application segment of the orthopedic implants market is segmented into neck fracture, spine fracture, hip replacement, shoulder replacement and others.
· On the basis of end user, the orthopedic implants market is segmented into hospital, orthopedic clinics, home cares and others.
Top Players Analysed in the Report are:
· CONMED Corporation (US)
· Wright Medical Group N.V. (US)
· Stryker (U.S.)
· Medtronic (Ireland)
· Smith+Nephew (UK)
· Zimmer Biomet (US)
· Integra LifeSciences (US)
· B. Braun Melsungen AG (Germany)
· Arthrex (US)
· Baxter (US)
· Medical Device Business Services, Inc. (US)
· Globus Medical (US)
· DJO, LLC (US)
· NuVasive, Inc (US)
· Orthopedic Implant Co (NV)
· Aesculap Inc. (USA)
· Flexicare Medical Limited (UK)
· BioTek Instruments, Inc. (US)
· Narang Medical Limited (India)
· Auxein Medical (India)
· Uteshiya Medicare (India)
Global Dural Repair Market Synopsis:The market dynamics study of an influential Dural Repair Market report demonstrates the scope of the various commercial possibilities over the coming years and the positive revenue forecasts in the years ahead.
Important industry trends, Market size, Market share estimates are analysed and mentioned in the industry analysis report.
The large scale Dural Repair Market report helps business in knowing its Market share over various time periods, transportation, storage, and supply requirements of its products.Under competitive Market share evaluation, it suggests that key players dominate the operations in the industry attributable to their strong geographical reach and huge production facilities.
The Market study aids in making sales forecasts for its products and thereby, establishing harmonious adjustment between demand and supply of its products.
According to the market report analysis, Dura Repair is generally used in neurosurgical procedures to repair defects in the dura, the dura mater is the dense, leathery membrane protecting & covering the spinal cord & brain.
It can get damaged in several ways such as tumor, severe head injury or invasive surgical procedures.The most significant key factors driving the growth of the Global Dural Repair Market are rising geriatric population prone severe injuries, increasing advancement in technology to provide suitable dura substitutes, rising number of accidents & rising cases of tumor.Global Dural Repair Market Segmentation:On the basis of Type, the dural repair market is segmented into biological dural repair & synthetic dural repairBased on the Application, the dural repair market is segmented into neurosurgery, spine surgery & othersBased on the End-User, the Dural repair market is segmented into hospitals, ambulatory surgery centers & othersRegionally, North America dominates the Dural Repair Market due to the presence of patient specific health care systems & its developed health care infrastructure.
According to the new market research report “Regenerative Medicine Market by Type [Cell-Based Immunotherapy & Cell Therapy (Allogeneic & Autologous Products), Tissue Engineering, Gene Therapy], Applications (Wounds & Dermal, Musculoskeletal, Oncology), Region — Global Forecast to 2024”, published by MarketsandMarkets™, the Regenerative Medicine Market is expected to reach USD 38.7 billion by 2024 from USD 13.3 billion in 2019, at a CAGR of 23.8%.Growth in this market is largely driven by the introduction of Cures Act for regenerative medicine by FDA, increased funding for regenerative medicine research, development of CAR-T cell therapies and increasing demand for regenerative medicine for the treatment of cancer, orthopedic disorders, and chronic wounds among others.
Cell-based immunotherapy & cell therapy products segment dominated the Regenerative Medicine Market in 2019.On the basis of type, the Regenerative Medicine Market is classified into cell-based immunotherapy & cell therapy products, gene therapy products, and tissue-engineered products.
The cell-based immunotherapy & cell therapy products segment accounted for the largest market share in 2019 owing to increasing demand for cell-based immunotherapies, the establishment of cures act by FDA to streamline the regenerative medicine approval are the major factors driving the growth of this market segment.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579Browse and in-depth TOC on “Regenerative Medicine Market”76 — Tables29 — Figures107 — PagesMusculoskeletal disorders applications segment likely to dominate the market in 2019.On the basis of application, the Regenerative Medicine Market is categorized into musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications.
In 2019, the musculoskeletal disorders segment accounted for the largest market share.
The large share of this segment can mainly be attributed to the rising incidence rate of orthopedic diseases with a rising geriatric population.North America anticipated accounting for the largest share of the Regenerative Medicine Market in 2019.The Regenerative Medicine Market in North America is expected to account for the largest share globally and also grow at a faster rate during the forecast period.
Surging research activities in the field of regenerative medicine, the introduction of CAR-T cell therapies and growing awareness of personalized medicine have also resulted in the establishment of stem cell banking and tissue engineering.Read a Press Release on “Regenerative Medicine Market”:https://www.marketsandmarkets.com/PressReleases/regenerative-medicine.aspThe major players in this market are Kite Pharma (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US), Wright Medical (US), MiMedx (US), Osiris Therapeutics (US), Stryker Corporation (US), and Spark Therapeutics (US).
